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SUMMARY : CDDP is one of the anticancer drugs in which the presence of the 
repair mechanism has been pointed out. Thus, using established pulmonary cancer 
cells, we evaluated the metabolism of DNA and RNA in damaged cells treated with 
CDDP (0.1, 1.0, 10µg/ml) by means of 3 H-TdR•3 H-UR incorporation assay for 15 
days referring to the growth curve and colony forming assay. 3H-TdR uptake inhibi-
tion rate in CDDP treatment was higher than 3H-UR uptake inhibition rate and 
showed good correlation with the inhibition rate of colony formation. In order to 
evaluate the activity of metabolism of DNA and RNA, the experimental period was 
divided into two parts : an early stage (2-10 days) and a later stage (7-15 days), and 
changing phases of uptake of 3H-TdR and 3H-UR was estimated as an increased 
rate. In the early stage, cells treated CDDP at lower concentrations tended to show 
more active DNA and RNA metabolism, especially RNA. In the later stage, cells 
with 0.1µg/ml CDDP which had shown only slight growth inhibition in the early 
stage revealed lower activity than that in the early stage. Cells with 1.0µg/ml CDDP 
which showed regrowth after 7 days, and cells with 10µg/ml CDDP which were not 
recognized with proliferation were observed with more active metabolism of RNA 
than that in the early stage. Those results indicated that metabolism of RNA is 
closely associated with the cellular repair process by CDDP.
       INTRODUCTION 
 At present, cis-diamminedichlorolplatinum 
(II) (CDDP) plays a major role in chemothe-
rapy for various solid cancers. Especially, 
combination therapy of CDDP and Bleomycin 
(BLM) is highly effective, so that the response 
rate is 70% in cases of pulmonary squamous 
cell cancer and 79% in cases of cancer of neck
and head'),'). However, KuRrrA et al.3)reported 
that findings in investigations of tissues in 
combination therapy of CDDP and pepleomycin 
for cancer of neck and head showed that clini-
cal effects (tumor reduction) did not always 
correspond to histological effects and poor 
prognosis was seen in cases that had high 
cellular degeneration and increased nuclear 
atypic in remaining cancer cells after chemo-
therapy. In the actual clinical field, we have
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experienced many cases that obtained effective 
clinical outcomes at an early stage but were 
eventually recognized as recurrence and meta-
stasis after that. 
  Thus, when regrowth of cancer cells in clini-
cally effective cases is considered, it is neces-
sary to take into consideration the presence of 
the repair mechanism of damaged cells by the 
anticancer drugs. Although the mechanism is 
not recognized in all anticancer drugs, the 
presence of the repair mechanism with CDDP 
and BLM is generally pointed out and many 
studies on it have been conducted 4)-lo) Thus, 
we consider the necessity of effective drug 
administration for the purpose of inhibition of 
repair ability as maintenance therapy after the 
treatment by anticancer drugs. This time, We 
studied on this matter from the aspect of long-
term metabolism of nucleic acid and conducted 
a basic experiment in which would be used 
DNA or RNA synthesis inhibitor as the blocker 
of repair using 3H incorporation assay. 
   MATERIALS AND METHODS 
1. Cells 
 The human cell line PC 1 of pulmonary squa-
mous cell cancer which grow as monolayers 
(kindly supplied by Dr. Y. HAYATA of Tokyo 
Medical College, Japan) were grown in RPMI 
1640 medium (GIBCO) supplemented with 10% 
fetal bovine serum (FBS, GIBCO). During the 
experiment, medium was exchanged once in 
every third day. 
2. Anticancer drugs and reagent 
 CDDP (Provided by Nippon Kayaku Co., Ltd. 
Japan) was added with a final concentration 
of 0.1,u g/ml, 1.0 ,u g/ml or 10 ,u g/ml at 24 
hours after plating in dish. The exposure 
time was determined to be 2 hours, and the 
cultured cells were subsequently washed by 
PBS (-) and fresh medium was exchanged. 
Additionally, Mitomycin C (MMC, provided 
by Kyowa Hakko Co., Ltd. Japan) and Adria-
mycin (ADM, provided by Kyowa Hakko Co., 
Ltd. Japan ), with concentration at which 
similar cell growth kinetics to CDDP 10 g g/ml 
were demonstrated, were investigated. 3H-
thymidine (3H-TdR, Amersham international
plc. specific activity : 20 Ci/nmol) and 3H-
unidine (3H-UR, Amersham international plc. 
specific activity : 20.7 Ci/nmol) were adjusted 
to 1 ,uCi/ml by diluting RPMI 1640 supple-
mented with 10% FBS and then stored at 4°C. 
3. Growth curve 
 5 X 104 cells/ml was plated in a 36 mm dish, 
and CDDP at each concentration was added 
after 24 hours and exposed with the cells for 2 
hours. Subsequently, the growth curve for 15 
days was studied. Viable cells were counted 
using Trypan Blue dye exclusion test. 
4. Colony forming assay 
 For investigation of colony formation, a 
flat bottom microplate with 96 wells (CORN-
ING 25870) was used. Medium 0.1 ml contain-
ing 3 X 102 cells was placed in each well. Twenty-
four hours later, CDDP with each concentra-
tion was added, and 0. 1 ml of fresh medium 
was then exchanged after wash. The cells were 
stained by Giemsa stain at days 7 and 15 in 
order to measure small colonies of more than 
8 cells under the microscope 11). The inhibition 
rate of colony formation was calculated by 
(1-number of colonies of sample /number of 
non-treated cells (control)) X 100. 
5. 3H-TdR and 3H-UR incorporation assay 
 The experiment was conducted under the 
same condition for colony formation, that is, 
0.1 ml of 1.0 ,u Ci/ml 3H-TdR and 3H-UR was 
added in 0.1 ml sample medium in a flat-bottom 
microplate with 96 wells at 2, 5, 10 and 15 
days, and labeling time of 24 hours was then 
taken. Following the labeling, at tached cells 
were treated using 0.25% typsin. Subsequently, 
the cells were treated with 5 % TCA for 3 0 
minutes at 4 °C. Following that, the cancer 
cells harvested to a paper (LM 101-10. Lab. 
Science ) using Automatic cell harvester 
(LABOMASH. Labo. science ), were again 
washed twice by 5% TCA and were then dried 
at room temperature. In order to calculate 
intracellular uptake of 3H-TdR and 3H-UR by 
cpm using a fluid scintilation counter (ALOKA 
Liquid Scintilation system. SC-903), 0.5 ml 
NCS tissue solution and 6ml scintilation fluid 
were added to the sample. The inhibition rate
of 3H-TdR and 3H-UR uptake was determined 
by (1-cpm of sample /cpm of control) X 100. 
The increase rate of the early stage and the 
late stage was calculated by (cpm of sample at 
10 days /cpm of sample at 2 days - cpm of 
control at 10 days/cpm of control at 2 days) 
X 100 and (cpm of sample . at 15 days /cpm of 
sample at 7 days =cpm of control at 15 days/ 
cpm of control at 7 days) X 100, respectively. 
          RESULTS 
1. Growth curve 
 CDDP 0.1 ,u g/ml resulted in cell growth 
kinetics similar to those of the control. With 
CDDP 1.0 ,u g/ml the cells tended to show 
inhibition of proliferation up to 7 days and 
then to reveal regrowth. The concentration of 
10 ,u g/ml resulted in reduction of number of 
cells, but not marked reduction, so that a 
constant number was seen after 7 days and 
viable cells of 1.1 X 104 cells /ml remained at 
10-15 days (Fig. 1). 
2. Colony forming assay 
 Table 1 shows the number of colonies of PC-
1 cells at days 7 and 15. The number of colonies 
of the control at day 7 was 39.1, however, the 
number at day 15 was not counted due to fusion 
among colonies. The inhibition rate of colony
Fig. 1. Growth curve of PCl cells after treatment 
       with several concentration of CDDP. 
       Point, average results of 3 determination.
formation with CDDP 0.1 ,u g /ml at day 7 
was 56.7%, whereas that at day 15 could not 
be evaluated due to the similar fusion. CDDP 
1.0 ,u gml resulted in a remarkable inhibition 
rate of colony f orMation by 84.7 % at day 7.
Table. 1. Evaluation of colony forming assay of PCl cells after treatment with several concentration 
       of CDDP a).
                       No. of colonies at 7 days No. of colonies at 15 days 
Concentration                  N
o. of cells in colonies No. of cells in colonies 
  ( ,u g/ml) Total colonies Total colonies 
               8^-15 16^-31 32- 16-63 64-
  Control 20.7±14.2 9.7±3.1 8.7±3.2 39.1 Incalculability b) Incalculability 
    0.1 9.0± 1.7 5.0±0.0 3.0±1.7 17.0 Incalculability Incalculability 
            (56.5)c) (48.5) (65.2) (56.5) 
     1.0 3.0± 1.0 2.0±1.7 1.0±0.0 6.0 1.7±1.2 6.0±2.0 7.7 
            (85.5) (79.4) (88.1) (84.7) 
    10 0 0 0 0 0 0 0 
           (100) (100) (100) (100) 
 a) Data are shown as the mean ± the standard deviation (n=3). 
 b) Numbers of colonies could not be counted as fusion of the neighbour colonies. 
 c) Numbers in parenthesis are percentages of inhiiition rate of colony formation. 
       Inhibition rate (%)=(1- No. of colonies of sample cells) X100.                              
. of colonies of control cells
However, results in the investigation of the 
number of cell-forming colonies which showed 
6 colonies with more than 64 cells at day 15, 
indicated that colonies with more than 8 cells 
at day 7 were favorably, repeatedly divided. 
Colony formation with CDDP 10 ,u g/ml was 
not recognized at days 7 and 15. 
3. 3H-TdR and 3H-UR incorporation assay
 Fig. 2 shows the change of intracellular 
uptake of 3H-TdR and 3H-UR by CDDP under 
indentical condition of experiment of colony 
formation. Cells treated with 0. 1 g g /ml or 
1.0 4a g/ml tended to increase uptake of 3H-
TdR and 3H-UR similar to that in the control. 
On the other hand, cells with CDDP 10 g g/ml 
were not recognized to increase uptake of 3H-
TdR and 3H-UR up to day 7 but subsequently
Fig. 2. Follow-up changes of 3H-Thymidine and 3H-Uridine uptake in PCl cells after 
       treatment with several concentration of CDDP. Point, average results of 3 
       determination.
Table 2. Estimation of DNA and RNA activities by3H-Thymidine and3H-Uridine incorpo-
        ration assay of PC1 cells after treatment with several concentration of CD-pa).
                     % Inhibition b) % Increase c) 
Concentration 
                7 days 15 days 10 days/2 days 15 days/7 days 
  ( ,u g/ml) 3
H-TdR 3H-UR 3H-TdR 3H-UR 3H-TdR 3H-UR 3H-TdR 3H-UR 
    0.1 47.3 12.6 22.9 5.6 188.1 241.9 146.6 108.7 
     1.0 74.9 56.8 75.9 46.4 36.1 50.6 96.0 124.0 
     10 97.6 98.1 99.1 96.3 4.0 8.6 35.6 196.2 
a) Numbers are percentages of average results (n= 3). 
b) % Ithibition= (1- cpm of sample cells) x 100.                cpm of control cells 
 % Increase cpm of sample cells at 10 days cpm of comtrol cells at 10 days c) % of 10 days/2 days= x 100.                       cpm of sample cells at 2 days cpm of comtrol cells at 2 days 
   Increase of 15 c m of sample cells at 15 days - cpm of comtrol cells at 15days x          days/7 days=cpm ofsample cells at 7days cpm ofcomtrol cells at7days 100.
tended to increase. This change was investigat-
ed by means of comparisons of inhibition rate 
(% inhibition) and increase rate (% increase) 
(Table 2). Inhibition rate of 3H-TdR with 0.1 
,u g/ml or 1.0 ,u g/ml at day 7 was compa-
rable with inhibition rate of colony formation 
at day 7 and higher than inhibition rate of 3H-
UR. Cells treated with CDDP 10 jug/ml 
which did not show colony formation revealed 
a remarkable inhibition rate of 3H-TdR and 3H-
UR. Although reduction of inhibition rate of 
3H-TdR and 3H-UR was seen with CDDP 0.1 
,u g /ml at day 15, a similar inhibition rate 
was observed for cells with 1.0 ,u g /ml and 
with 10,4g/ml at day 7 and 15. On the other 
hand, an increased rate of 3H-TdR and 3H-UR 
from day 2 to 10 resulted in a higher rate with 
lower concentration of CDDP. Increase rate 
with 0.1ji g/ml from day 7 to 15 decreased 
in both 3H-TdR and 3H-UR more than those 
from day 2 to 10, especially, the rate for 3H-
UR. On the other hand, the rate from day 7 to 
15 with 1.0 or 10 ,u g/ml was higher than that 
from day 2 to 10 for 3H-TdR and 3H-UR, and 
the rate for 3H-UR was higher than that for 
3H-TdR. Especially, the rate for 3H-UR with 
10 g g/ml from day 7 'to 15 was the highest 
in the later stage. That is, RNA synthesis 
tended to become active with CDDP of high 
concentration at the later stage. 
4. 3H-TdR and 3H-UR incorporation assay 
 using other drugs 
  A comparison study was conducted between 
variation of uptake of 3H-TdR and 3H-UR with 
CDDP 10 ,u g/ml and variation of uptake with 
MMC 5.0,u g/ml or ADM 1.0 ,u g/ml which 
reveals similar cell growth kinetics to CDDP 
10 ,u g/ml (Fig. 3). Variation of uptake of 
3H-TdR with MMC or ADM tends to be similar 
to that with CDDP, although it was, a low 
value. However, variation of uptake of 3H-UR 
with MMC or ADM after 7 days did not result 
in an increase of uptake, which was different 
to results of CDDP. 
         DISCUSSION 
 CDDP is considered to be a DNA synthesis 
inhibitor which shows antitumor effect by
Fig. 3. Follow-up changes of 3H-Thymidine and 
      3H -Uridine uptake in PCl cells after 
      treatment with CDDP 10 ,u g /ml, ADM 
       1.0 ,u g/ml and MMC 5.0 ,u g /ml. Point, 
       average results of 3 determination.
means of interstrand cross-links or intrastrand 
cross-links with DNA 6)'12). HowLE et al. 13) also 
reported that although long reduction of DNA 
synthesis recognized using 3H incorporation 
assay, reduction of RNA synthesis and protein 
was seen transiently, and inhibition of DNA 
synthesis consequently played an important 
rule for antitumor effect. Inhibition rate 
measured by 3H incorporation assay in this 
experiment corresponded to results of HOWLE 
et al. However, it is necessary to think about 
the problem of recovery from damage when 
antitumor effect is considered. Damaged cells 
with 1.O,u g/ml of CDDP which is known for 
the presence of the . repair mechanism demons-
trated regrowth and reversibility in this study. 
Repair with CDDP, which has been known due 
to action of DNA excision repair mechanism, 
has been reported to be related to the residual 
amount of platinum in DNA 5 ). In addition, 
recent reports indicated that SOS response is 
induced by many DNA damaging agents, and 
mutagenesis and cytotoxicity by CDDP is 
affected by the SOS repair mechanism with 
sulA fusion mutant induction7). It is generally 
known that induction of SOS response occurs 
by activation of RectA protein by DNA damage 
and subsequent stimulation of cleavage of 
LexA protein. During this response, it is 
supposed that intracellular metabolism asso-
ciated with repair may be activated 14 ). How-
ever, the most basic long-term experiment with 
CDDP in nucleic acid metabolism seems not to 
have been conducted. Thus, variation of early 
metabolism (days 2-10) and later metabolism 
(days 7-15) was evaluated as increase rate 
(follow-up variation) of 3H-TdR and 3H-UR 
uptake in treated cells against that in non-
treated cells. In the early stage, increase rate 
of 3H-UR was higher than that of 3H-TdR at 
any concentration of CDDP, and a higher rate 
of 3H-UR was recognized at lower concentration 
of CDDP. In contrast, in the later stage, 3H-
UR showed a higher rate at higher concentra-
tion of CDDP, and the highest rate was seen 
at 10 ,u g /ml. These results indicated that 
RNA metabolism, rather than DNA metabo-
lism, becomes active first and becomes more 
active at higher concentration of CD.DP in 
recovery of damaged cells. It was not determin-
ed if such a tendency is a specific phenomenon 
for CDDP. Also, the tendency in MMC and 
ADM which have not been generally known for 
presence of the repair mechanism was not 
clarified. 
 Studies of CDDP with respect to presence of 
repair mechanism have been progressing ; 
CDDP-damaged cells is known to be reversible. 
This study on the nucleic acid metabolism 
proved that RNA metabolism is activated first 
in the repair process of CDDP-damaged cells. 
Especially, it is remarkable that activity of 
RNA metabolism was observed in 101a g/ml 
CDDP which did not have the capacity for 
colony formation. In additon, BLM which is
used in combination of CDDP is known to 
have the repair mechanism 8)- 10).. NisHIKDRi et 
al. 8 ) reported that Actinomycin D of RNA 
synthesis inhibitor inhibited the action of 
recovery from BLM damage, because it was 
considered that Actinomycin D possibly inhibit-
ed RNA metabolism in the repair process. If 
intracellular activity of RNA metabolism is 
necessary for recovery and reproliferation of 
anticancer-induced damage cells, it is empha-
sized that RNA synthesis inhibitors may be 
one of beneficial drugs administerd after 
induction therapy of CDDP and/or BLM. 
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